Zakrzewski J L, Ballauff A, Wieland R, Basu O, Kremens B
University Hospitals of Essen, Department of Pediatric Hematology, Oncology and Endocrinology, Essen, Germany.
Pediatr Hematol Oncol. 2004 Dec;21(8):697-705. doi: 10.1080/08880010490514741.
Hepatic complications associated with cholestasis occur frequently in hematopoietic stem cell transplant recipients. Since bile acid seems to be a sensitive indicator of beginning cholestasis, the authors monitored total serum bile acid levels in addition to the standard liver function tests in 23 recipients of allogeneic transplants between June 1999 and September 2000. The observations suggest that bile acid is an early and sensitive marker of hepatic GvHD but not as specific as bilirubin. For cholestasis in absence of hepatic GvHD bile acid seems to be more sensitive than bilirubin. Routinely monitoring of bile acid after hematopoietic stem cell transplantation is not indicated.
胆汁淤积相关的肝脏并发症在造血干细胞移植受者中频繁发生。由于胆汁酸似乎是胆汁淤积开始的敏感指标,作者在1999年6月至2000年9月期间,对23例异基因移植受者除进行标准肝功能检查外,还监测了血清总胆汁酸水平。观察结果表明,胆汁酸是肝脏移植物抗宿主病(GvHD)的早期敏感标志物,但不如胆红素特异。对于无肝脏GvHD的胆汁淤积,胆汁酸似乎比胆红素更敏感。造血干细胞移植后常规监测胆汁酸并无必要。